AzTrials
AzTrials

AnxietyNCT07908771

Virtual Reality for Anxiety and Birth Satisfaction During Elective Cesarean Section

A study testing Virtual Reality Distraction in people with Anxiety and Cesarean Section, run by Tarsus University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study will examine whether virtual reality during planned cesarean birth reduces women's anxiety and improves their satisfaction with the birth experience. The study will include 144 women undergoing elective cesarean section under spinal anesthesia at Adana City Training and Research Hospital in Türkiye. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Anxiety, Cesarean Section, Birth Satisfaction
What is being tested?
Virtual Reality Distraction
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
144 participants
Where
1 siteTurkey (Türkiye)
Study dates
Nov 2026to 30 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Women scheduled for elective cesarean section
  • Singleton pregnancy
  • Term pregnancy (≥37 weeks of gestation)
  • Cesarean section planned under spinal anesthesia
  • Aged 18 years or older
  • Able to read, write and communicate in Turkish
  • Voluntary participation and written informed consent

Who cannot join

  • Intrauterine fetal death
  • Major fetal congenital anomaly
  • Failed spinal anesthesia requiring conversion to general anesthesia, or planned general anesthesia
  • Visual or hearing impairment preventing use of virtual reality
  • History of epilepsy, vertigo or motion sickness
  • Diagnosed psychiatric disorder or regular use of anxiolytic/antidepressant medication

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Adana City Training and Research Hospital

    Adana, Adana, 01370

    Kübra Bozkurt, Bsc, +90.322 455 90 00, ankgungork13@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of an Intraoperative Virtual Reality Intervention on State Anxiety and Cesarean Birth Satisfaction in Women Undergoing Elective Cesarean Section: A Randomized Controlled Trial

This study will examine whether virtual reality during planned cesarean birth reduces women's anxiety and improves their satisfaction with the birth experience.

The study will include 144 women undergoing elective cesarean section under spinal anesthesia at Adana City Training and Research Hospital in Türkiye. Participants will be randomly assigned to one of two groups. One group will receive routine care and watch a relaxing nature video with natural sounds through a virtual reality headset during surgery. The other group will receive routine care alone.

Read more

Virtual reality will be paused when the baby is born so that anxiety can be assessed and the mother can see her baby. It will then resume until surgery ends.

Anxiety and vital signs will be assessed before surgery and 15-30 minutes after completion of surgery, once the participant is clinically stable. An additional brief anxiety assessment will be performed immediately after birth, before the mother first sees her baby. Satisfaction with cesarean birth will be assessed 6-8 hours after birth.

The researchers will compare the results between the two groups to evaluate the effects of virtual reality on maternal anxiety and cesarean birth satisfaction.

Read the detailed description

This single-center, two-arm, parallel-group randomized controlled trial will evaluate an intraoperative virtual reality intervention in women undergoing elective cesarean section under spinal anesthesia. The planned sample is 144 women, with 72 participants assigned to each group.

Randomization and Allocation Concealment A computer-generated randomization sequence with a 1:1 allocation ratio and variable block sizes of four and six has been generated using Sealed Envelope. The sequence will be held by an independent person who is not involved in participant recruitment or intervention delivery. Sequentially numbered, opaque, sealed envelopes will be prepared before recruitment. After eligibility confirmation, written informed consent, and baseline assessments, the next envelope in numerical order will be opened to determine group assignment.

Intervention Virtual reality will begin after the effectiveness of spinal anesthesia has been confirmed. Participants will view the same standardized 360-degree nature video featuring forest, water, and wildlife scenes with natural sounds, without speech or guided meditation. The video lasts approximately 20-30 minutes and will be restarted if necessary.

At the baby's birth, virtual reality will be paused. The Face Anxiety Scale will be administered immediately after birth and before the mother's first meeting with her baby. After this assessment, routine newborn care and the mother's opportunity to see her baby will take place. Virtual reality will then resume until the end of surgery.

The control group will receive routine care alone, with assessments at the same time points.

Assessments State anxiety will be assessed using the State-Trait Anxiety Inventory, State Subscale (STAI-I), before surgery (prior to randomization) and 15-30 minutes after completion of surgery, once the participant is clinically stable.

The Face Anxiety Scale will be administered at three time points: before surgery (prior to randomization), immediately after birth and before the mother's first meeting with her baby, and 15-30 minutes after completion of surgery, once clinically stable.

Systolic and diastolic blood pressure, heart rate, respiratory rate, and peripheral oxygen saturation will be recorded before surgery (prior to randomization) and 15-30 minutes after completion of surgery, once the participant is clinically stable.

Cesarean birth satisfaction will be assessed 6-8 hours postpartum using the Cesarean Birth Satisfaction Scale.

Masking Participants and the researcher delivering the intervention cannot be blinded. Data entry will be performed by an independent researcher unaware of group assignments, using groups coded as A and B. Statistical analyses will be conducted by a statistician unaware of which intervention each code represents. Group identities will be disclosed after the analyses are completed.

Statistical Analysis Data will be analyzed using appropriate statistical methods according to the measurement level and distribution of each outcome. The primary outcome, postoperative state anxiety, will be compared between groups with adjustment for baseline anxiety scores. Repeated measurements of Face Anxiety Scale scores will be analyzed using methods appropriate for ordinal longitudinal data. Vital signs will be compared between groups with adjustment for baseline measurements. Cesarean birth satisfaction scores will be compared between groups using appropriate statistical tests. Results will be reported with 95% confidence intervals and relevant effect size estimates. Statistical significance will be set at p < 0.05. Missing data will be assessed and reported.

Being tested
Virtual Reality Distraction
Keywords
Virtual Reality, Elective Cesarean Section, State Anxiety, Cesarean Birth Satisfaction
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality DistractionDevice

    Participants in the intervention group will receive a standardized immersive virtual reality (VR) session via a head-mounted display with headphones during elective cesarean section under spinal anesthesia, in addition to routine care. The VR headset will be applied after adequate spinal block is confirmed. Content is a 360-degree nature video (forest, water and wildlife scenes) with natural sounds, without speech or guided meditation, lasting about 20-30 minutes and restarted if surgery lasts longer. VR will be paused at the birth of the baby for the intraoperative Face Anxiety Scale assessment and the first mother-infant contact, then resumed until the end of surgery. Volume and fit will be adjusted for comfort. VR will be stopped immediately if dizziness, nausea, headache or other discomfort occurs, or if clinically required.

Study groups in NCT07908771
Study groupRoleWhat they receive
Virtual Reality Plus Routine CareExperimentalParticipants will receive intraoperative virtual reality in addition to routine care during elective cesarean section under spinal anesthesia. After effective spinal anesthesia is confirmed, a standardized 360-degree nature video with natural sounds will be presented through a virtual reality headset. The intervention will be paused at birth for the Face Anxiety Scale assessment and the mother's first meeting with her baby, then resumed until surgery ends.
Receives: Device: Virtual Reality Distraction
Routine CareNo interventionParticipants will receive routine care during elective cesarean section under spinal anesthesia, without virtual reality or any additional study intervention. Assessments will be performed at the same time points as in the experimental group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. State Anxiety

    State anxiety will be assessed using the State-Trait Anxiety Inventory - State Subscale (STAI-I), Turkish version. Scores range from 20 to 80; higher scores indicate higher anxiety levels.

    Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable

Secondary outcomes (7)
  1. Face Anxiety Score

    Momentary anxiety will be assessed using the single-item Face Anxiety Scale (Turkish version). Scores range from 1 to 5; higher scores indicate higher anxiety.

    Measured: Preoperatively (before randomization), intraoperatively (immediately after birth, before first mother-infant contact), and 15-30 minutes after completion of surgery, once clinically stable

  2. Cesarean Birth Satisfaction

    Cesarean birth satisfaction will be assessed using the 11-item Cesarean Birth Satisfaction Scale. Scores range from 11 to 55; higher scores indicate greater satisfaction.

    Measured: 6-8 hours postpartum

  3. Systolic Blood Pressure

    Systolic blood pressure (mmHg) will be measured and recorded on the Vital Signs Monitoring Form.

    Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable

  4. Diastolic Blood Pressure

    Diastolic blood pressure (mmHg) will be measured and recorded on the Vital Signs Monitoring Form.

    Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable

  5. Heart Rate

    Heart rate (beats per minute) will be measured and recorded on the Vital Signs Monitoring Form.

    Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable

  6. Respiratory Rate

    Respiratory rate (breaths per minute) will be measured and recorded on the Vital Signs Monitoring Form.

    Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable

  7. Peripheral Oxygen Saturation (SpO₂)

    Peripheral oxygen saturation (%) will be measured by pulse oximetry and recorded on the Vital Signs Monitoring Form.

    Measured: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2026
  2. Study startNov 2026 (estimated)
  3. Primary completion30 Apr 2027 (estimated)
  4. Study completion30 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two-arm, parallel-group randomized controlled trial. Participants will be assigned in a 1:1 ratio to intraoperative virtual reality plus routine care or routine care alone, using variable block randomization.
Masking
None (open label)
Enrolment
144 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07908771
Sponsor's protocol ID
Tarsus-Kubra-VR-2026
Status last verified
Oct 2026
First submitted
25 Oct 2026
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared publicly in order to protect participant confidentiality, in accordance with the Turkish Personal Data Protection Law (KVKK, No. 6698) and the informed consent obtained, which does not include permission for data sharing with third parties. Aggregated results will be reported in the thesis and in peer-reviewed publications.

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Distraction in people with Anxiety and Cesarean Section, run by Tarsus University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ayşe ŞENOĞLU, PhD (90 (324) 600 00 33 ext. 2226, aysesenoglu@tarsus.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

State Anxiety (time frame: Preoperatively (before randomization) and 15-30 minutes after completion of surgery, once clinically stable). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in